MHIP vs. IDNA
MHIP (Milliman Healthcare Inflation Plus ETF) and IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) are both Health & Biotech Equities funds. MHIP is actively managed, while IDNA is passively managed. A 0.61 correlation means they provide meaningful diversification when combined. MHIP charges 0.55%/yr vs 0.47%/yr for IDNA.
Performance
MHIP vs. IDNA - Performance Comparison
Loading charts...
Returns By Period
MHIP
- 1D
- 0.60%
- 1M
- 0.71%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IDNA
- 1D
- -1.42%
- 1M
- 9.31%
- 6M
- 16.31%
- YTD
- 25.19%
- 1Y
- 54.34%
- 3Y*
- 12.07%
- 5Y*
- -6.60%
- 10Y*
- —
MHIP vs. IDNA - Yearly Performance Comparison
Correlation
The correlation between MHIP and IDNA is 0.61, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Apr 21, 2026 | 0.61 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MHIP vs. IDNA — Risk / Return Rank
MHIP
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
IDNA
MHIP vs. IDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Milliman Healthcare Inflation Plus ETF (MHIP) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MHIP | IDNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.34 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 5.12 | — |
| Martin ratioReturn relative to average drawdown | — | 14.05 | — |
Loading charts...
Drawdowns
MHIP vs. IDNA - Drawdown Comparison
The maximum MHIP drawdown since its inception was -3.09%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for MHIP and IDNA.
Loading charts...
Drawdown Indicators
| MHIP | IDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -3.09% | -68.26% | +65.17% |
Max Drawdown (1Y)Largest decline over 1 year | — | -10.66% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -29.46% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -68.26% | — |
Current DrawdownCurrent decline from peak | -1.47% | -38.27% | +36.80% |
Average DrawdownAverage peak-to-trough decline | -1.28% | -36.28% | +35.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 3.88% | — |
Volatility
MHIP vs. IDNA - Volatility Comparison
Loading charts...
Volatility by Period
| MHIP | IDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 7.13% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 18.71% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 11.54% | 25.18% | -13.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 11.54% | 28.52% | -16.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 11.54% | 29.49% | -17.95% |
MHIP vs. IDNA - Expense Ratio Comparison
MHIP has a 0.55% expense ratio, which is higher than IDNA's 0.47% expense ratio.
Dividends
MHIP vs. IDNA - Dividend Comparison
MHIP has not paid dividends to shareholders, while IDNA's dividend yield for the trailing twelve months is around 0.86%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 0.86% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
MHIP Milliman Healthcare Inflation Plus ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
MHIP and IDNA have a correlation of 0.61, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IDNA is cheaper at 0.47% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IDNA is cheaper with a 0.47% expense ratio, compared with 0.55% for MHIP.
IDNA has the higher dividend yield at 0.86%, compared with 0.00% for MHIP.
They also come from different issuers: Milliman and iShares. Their fees differ too: 0.55% for MHIP and 0.47% for IDNA.
Find the right allocation for MHIP and IDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer